VRTXVertex Pharmaceuticals, Inc.
VRTX
Vertex Pharmaceuticals, Inc.12,723
Mkt Cap
$110.28BVolume
1.75M52W High
$507.9252W Low
$362.50PE Ratio
25.76VRTX Fundamentals
Price
$434.52Prev Close
$433.54Open
$437.0750D MA
$440.29Beta
0.57Avg. Volume
1.07MEPS (Annual)
$15.32P/B
5.70Rev/Employee
$1.89M$112,391.78
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.
A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Ava Bio's Cell-Based Platform Approach
A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Ava Bio's Cell-Based Platform Approach A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a...
Vertex to Participate in Upcoming May Investor Conferences
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences. Charlie Wagner, Chief Operating and Financial Officer, will...
VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings
Vertex's new drugs are gaining momentum as Alyftrek tops $1 billion in sales and Journavx prescriptions accelerate.
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Biotech Stocks To Add to Your Watchlist - May 6th
Danaher, Avalo Therapeutics, Vertex Pharmaceuticals, United Therapeutics, argenex, ImmunityBio, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that use biological science and technology t...
Vertex Announces CASGEVY Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that a reimbursement agreement was signed with the GKV-Spitzenverband for its CRISPR/Cas9 gene-edited therapy, CASGEVY...
QRG Capital Management Inc. Increases Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
QRG Capital Management Inc. increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 16.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 18,396 shares of the pharmaceutical company's stock after...
Principal Financial Group Inc. Boosts Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Principal Financial Group Inc. increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 415,100 s...
M&T Bank Corp Increases Holdings in Vertex Pharmaceuticals Incorporated $VRTX
M&T Bank Corp boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 19.5% during the fourth quarter, according to the company in its most recent filing...
<
1
2
...
>
Compact View
Not available
Not available